ask="1.32"
ask_size="1000"
average_daily_volume="107398"
bid="0.67"
bid_size="800"
book_value="0.53"
change="-0.02"
change_from_200_day_moving_average="-0.47"
change_from_50_day_moving_average="-0.26"
change_from_52_week_high="-7.02"
change_From_52_week_low="0.01"
change_in_percent="-2.11%"
close="0.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.01"
ebitda="-15.83M"
eps_estimate_current_year="-0.82"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="6119000"
high="0.95"
high_52_weeks="7.95"
last_trade_date="3/7/2017"
last_trade_price="0.93"
last_trade_size="100"
last_trade_time="4:00pm"
low="0.92"
low_52_weeks="0.92"
market_capitalization="15.24M"
moving_average_200_day="1.40"
moving_average_50_day="1.19"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.00"
open="0.93"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-33.79%"
percent_change_from_50_day_moving_average="-21.92%"
percent_change_from_52_week_high="-88.30%"
percent_change_from_52_week_low="+1.09%"
previous_close="0.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.79"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.23"
stock_exchange="NGM"
symbol="ORPN"
volume="39264"
weeks_range_52="0.92 - 7.95"
